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Abstract
Background: The Polycomb group (PcG) of proteins is a family of important developmental regulators. The respective
members function as large protein complexes involved in establishment and maintenance of transcriptional repression of
developmental control genes. MBTD1, Malignant Brain Tumor domain-containing protein 1, is one such PcG protein. MBTD1
contains four MBT repeats.
Methodology/Principal Findings: We have determined the crystal structure of MBTD1 (residues 130–566aa covering the 4
MBT repeats) at 2.5 A ˚ resolution by X-ray crystallography. The crystal structure of MBTD1 reveals its similarity to another
four-MBT-repeat protein L3MBTL2, which binds lower methylated lysine histones. Fluorescence polarization experiments
confirmed that MBTD1 preferentially binds mono- and di-methyllysine histone peptides, like L3MBTL1 and L3MBTL2. All
known MBT-peptide complex structures characterized to date do not exhibit strong histone peptide sequence selectivity,
and use a ‘‘cavity insertion recognition mode’’ to recognize the methylated lysine with the deeply buried methyl-lysine
forming extensive interactions with the protein while the peptide residues flanking methyl-lysine forming very few contacts
[1]. Nevertheless, our mutagenesis data based on L3MBTL1 suggested that the histone peptides could not bind to MBT
repeats in any orientation.
Conclusions: The four MBT repeats in MBTD1 exhibits an asymmetric rhomboid architecture. Like other MBT repeat proteins
characterized so far, MBTD1 binds mono- or dimethylated lysine histones through one of its four MBT repeats utilizing a
semi-aromatic cage.
Enhanced version: This article can also be viewed as an enhanced version (http://plosone.org/enhanced/pone.0007274/) in
which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a
web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are
available in Text S1.
Citation: Eryilmaz J, Pan P, Amaya MF, Allali-Hassani A, Dong A, et al. (2009) Structural Studies of a Four-MBT Repeat Protein MBTD1. PLoS ONE 4(10): e7274.
doi:10.1371/journal.pone.0007274
Editor: Nick Gay, University of Cambridge, United Kingdom
Received August 7, 2009; Accepted September 8, 2009; Published October 20, 2009
Copyright:  2009 Eryilmaz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the
Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice
Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co Inc., the Novartis Research Foundation, the
Swedish Agency for Innovationrefer Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jr.min@utoronto.ca
Introduction
The nucleosome is the fundamental repeating unit of chroma-
tin. The nucleosome core particle consists of approximately 147
base pairs of DNA wrapped around a histone octamer consisting
of 2 copies each of the core histones H2A, H2B, H3, and H4. The
four core histones are composed of a globular domain and an
unstructured tail. The unstructured tails protrude from the
nucleosome and are subject to a number of post-translational
modifications including acetylation, methylation, phosphorylation
and ubiquitylation [2]. Methylation of lysine and arginine residues
on the histones is an important regulator of eukaryotic
transcription and genome integrity. These post-translational
modifications are thought to act as markers that recruit proteins
to specific regions of chromatin [3].
The MBT (Malignant Brain Tumor) repeat is a structural motif
of ,100 amino acids that is conserved from C. elegans to humans
and exists as tandem repeats [4]. In the human genome, there are
at least 9 MBT repeat proteins, each containing two, three or four
MBT repeats, respectively. The MBT repeat was originally
identified in the Drosophila tumor-suppressor protein L(3)MBT
and mutations of L(3)MBT gene cause malignant transformations
of the optic neuroblasts [5]. Like other members in the ‘Royal
Family’ [6], MBT repeat proteins have been shown to recognize
methylated lysine residues on histones [7], and functional studies
have suggested important connections between MBT domain-
containing proteins and the transcriptional state of chromatin
regions [8,9,10,11,12,13].
Structural studies of MBT repeat proteins show that, unlike
chromodomain [14,15,16,17], MBT repeat proteins use a semi-
aromatic cage to accommodate the methyllysine [1,9,18,19,20,21].
The difference in the residue composition of the binding pocket of
the histone code effectors allows them to discriminate between
different lysine methylation states [19]. The chromodomain
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MBT repeats show specificity towards the lower methylation states
of lysine. To gain insight into the conservation of the semiaromatic
cage and its function in methyl recognition, we have determined
the structure of the 4-MBT repeat domain of human MBTD1 and
characterized its binding specificity against different histone
peptides.
Results and Discussion
MBTD1 is a four MBT repeat protein comprising 628 amino
acids. It contains a FCS-type zinc finger at the N-terminus with
putative regulatory function [22] and four MBT repeats at the
C-terminus. To investigate the crystal structure of the four
MBT repeat fragment of MBTD1 and characterize its histone
binding specificity, we cloned and purified a human MBTD1
fragment composed of all four MBT repeats (residues 130–566).
MBTD1130–566 crystallized in the orthorhombic space group
P212121 (a=70.31 A ˚, b=100.90 A ˚, c=135.30 A ˚ )w i t ht w o
molecules in the asymmetric unit (Figure 1). Crystal diffraction
data and refinement statistics for the MBTD1 structure are
displayed in Table 1. In the MBTD1 structure, each molecule
contains four MBT repeats that exhibit irregular rhomboid
architecture. A narrow channel runs through the middle of the
structure and is filled with water molecules. Consistent with
previously reported MBT repeat structures, each MBT repeat
contains an extended ‘‘arm’’ which packs against a globular b
subunit core of the preceding repeat [1]. Structural and
sequence alignment show that the b-barrel subunit core region
has the highest conservation between MBTD1 and other MBT
repeat proteins. The residues involved in intermolecular
hydrogen bond interactions between the two molecules in the
asymmetric unit are conserved throughout the whole MBT
repeat family, possibly implying that MBTD1 functions as a
dimer unit (Figure 2). Nonetheless, dynamic light scattering
(DLS) experiments and size exclusion experiments demonstrate
that MBTD1 is a monomer in solution at the working
concentrations (,5 mg/ml, data not shown). Structurally, the
last three MBT repeats in MBTD1 and L3MBTL2 form three-
blade propeller architecture. Superposition of the three MBT
repeats of L3MBTL1 with those of MBTD1 and L3MBTL2
shows a good structural alignment of Ca positions with a root-
mean-squared deviation (RMSD) of 2.345 A ˚ and 2.168 A ˚ ,
respectively. Furthermore, the MBTD1 can also be well
superimposed with L3MBTL2 with a root-mean-squared
deviation of 0.697 A ˚ .
To date, L3MBTL1 [18,20,23], L3MBTL2 [1], dScm [9],
dSFMBT [13] and SCML2 [21] have been shown to selectively
Figure 1. Overall structure of MBTD1. There are two MBTD1 molecules in the asymmetric unit, and each molecule contains four MBT repeats
(MBT1, MBT2, MBT3, MBT4), which exhibit irregular rhombus architecture.
doi:10.1371/journal.pone.0007274.g001
MBTD1
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possesses histone binding ability, we have carried out the
binding studies of the MBTD1 4MBT fragment against a set of
fluorescently labeled peptides derived from the N-terminal tails
of histones H3 and H4 by means of fluorescence polarization
technique (Figure 3). The data revealed that MBTD1
specifically binds to mono and di-methylated lysine on histone
H4K20 and exhibit negligible binding to the unmodified or
trimethylated peptides. Furthermore, the binding results also
show that MBTD1 weakly interacts with mono- or dimethy-
lated lysine histone peptides H3K9, H3K4 and H3K27. This
indicates that MBTD1 modestly selectively recognizes lower
methylated H4K20 peptide over other histone lysine methyl-
ation sites.
Although the four MBT repeats of MBTD1 have similar
three-dimensional structures and high sequence identity, only
the fourth MBT repeat (MBT4) contains the semi-aromatic
cage, which is formed by the loops between the first and
second strands and the third and fourth strands of the b-b a r r e l
core domain and constitutes the binding site for methyllysine
residue, analogous to L3MBTL2. The binding pocket of the
MBTD1-MBT4 is shown in Figure 4, where an open cage in
MBTD1 is formed by aromatic residues Phe526, Trp529,
Tyr533, negatively charged Asp502, and Leu508. Three highly
conserved aromatic residues Phe526, Trp529 and Tyr533 form
the base and the walls of the hydrophobic pocket. Interestingly,
Arg325 from a symmetry related molecule is inserted into the
binding pocket, mimicking the methyl-lysine binding in
L3MBTL2 [1]. The arginine residue 325 is stabilized by a
salt bridge with the pocket residue Asp502, and cation-p and
van der Waals and interactions with the aromatic cage
residues.
The utilization of a single MBT repeat for histone binding,
despite the structural and sequence similarity shared by all four
MBT repeats, is reminiscent of the histone binding mode
employed by other MBT containing proteins, including
L3MBTL1 [18,20]. This has been explored in parallel to
MBTD1, where only the second MBT domain (MBT2) of the
three MBT repeats in L3MBTL1 was bound to histone peptide.
Based on sequence and structural alignment, we attributed this
phenomenon to the steric hindrance generated by the long or
bulky side chain residues (phenylalanine in MBT1 and arginine
in MBT3) in the potential pockets instead of cysteine in MBT2.
We also suggested that the electrostatic repulsion between the
methyllysine and Arginine in MBT3 might be an additional
factor, which prevents histone peptide binding. To test our
hypothesis and to explore the possibilities of converting a
naturally ‘‘non-functional’’ methyllysine binding MBT to a
‘‘functional’’ state, we generated a L3MBTL1 Arg467Cys
mutant, which in principle should eliminate both the steric
hindrance and electrostatic repulsion in MBT3 based on our
prediction. Crystals of the L3MBTL1 R467C mutant were
successfully grew in the presence of excess amount of
H4K20me2 peptide. However, no electron density was
observed in the predicted binding site in the mutated MBT3.
ITC experiment of this mutant titrated with H4K20me2 also
suggests that there is only one binding site (data not shown).
Upon a closer examination of this mutant crystal structure,
another residue Arg461 was identified, which potentially
clashes with Arg17 on the histone peptide and therefore prevent
the methylated lysine histone from binding in this pocket
(Figure 5). In MBT2, the same position is occupied by Met357.
All known MBT-peptide complex structures characterized to
date do not exhibit strong histone peptide sequence selectivity,
and use a ‘‘cavity insertion recognition mode’’ to recognize the
methylated lysine with the deeply buried methyl-lysine forming
extensive interactions with the protein while the peptide
residues flanking methyl-lysine forming very few contacts [1].
Although a ‘‘functional’’ MBT3 was not obtained, this
mutagenesis study revealed that the histone peptide could not
bind to MBT repeats in any orientation.
Materials and Methods
Protein expression and purification
The human MBTD1 protein (residues 130–566) was subcloned
into pET28a-MHL vector and transformed in Escherichia coli BL21
(DE3)-V2R-pRARE2. Cells were grown in Luria-Bertanin media
at 37uC until they reach an absorbance at 600nm of approx-
imately 3.0, then cooled down to 14uC followed by induction with
1 mM of isopropyl-b-D-thiogalactoside (IPTG) overnight. Cells
were harvested by centrifugation at 7500 rpm for 15 minutes,
resuspended in a buffer solution containing 20 mM Tris 8.0,
250 mM NaCl, 10% glycerol and lyzed by sonication. The
supernatant fraction obtained by centrifugation at 16,000 rpm for
1 hour and passed through a Ni-NTA Superflow resin (QIAGEN)
that had been pre-equilibrated in 20 mM Tris-HCl (pH 8.0),
250 mM NaCl, 10% Glycerol, which was then washed and eluted
with 20 mM Tris-HCl (pH 8.0), 250 mM NaCl, 10% Glycerol,
500 mM imidazole. HiTrap Q HP column (GE Healthcare,
Piscataway, NJ) and Superdex 75 gel-filtration column (GE
Healthcare, Piscataway, NJ) were carried out for further
purification. The protein was concentrated to 10 mg/ml in a




a, b, c (A ˚) 70.31, 100.90, 135.30
a, b, c (u) 90.00, 90.00, 90.00
Number of molecules in asu 2
Resolution (A ˚) 2.5 (2.59–2.50)*
Rmerge (%) 9.1 (40.5)
I/sI 5.8 (4.1)
Completeness (%) 99.0 (93.1)
Redundancy 6.9 (5.3)
Refinement










Bond lengths (A ˚) 0.02
Bond angles (u) 1.8
doi:10.1371/journal.pone.0007274.t001
MBTD1
PLoS ONE | www.plosone.org 3 October 2009 | Volume 4 | Issue 10 | e7274Figure 2. Intermolecular interactions of the two MBTD1 molecules in the asymmetric unit. a) One molecule is shown as surface
representation and the other as ribbon representation with residues involved in the intermolecular interactions colored in green. b). Sequence
alignment among different MBT modules. All four MBT repeats in MBTD1 were aligned with the methyllysine binding MBT repeats in other MBT
proteins (the fourth MBT repeat in L3MBTL2, the second MBT repeat in L3MBTL1, the second MBT in SCMH1 and the second MBT repeat in SCML2).
Key residues participating in binding pocket formation are colored in blue and residues involved in the intermolecular interactions colored in green.
doi:10.1371/journal.pone.0007274.g002
Figure 3. Fluorescence polarization measurements of binding of different histone peptides against MBTD1. The data shows that
MBTD1 specifically binds to mono and di-methylated lysine on histone H4K20 and only exhibit negligible binding to the unmodified or trimethylated
peptides. In addition, MBTD1 was also shown to bind weakly to mono- or dimethylated lysine histone peptides H3K9, H3K4 and H3K27.
doi:10.1371/journal.pone.0007274.g003
MBTD1
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Glycerol, 1 mM EDTA and 1 mM DTT. The human L3 MBTL1
R467C mutants containing 3 MBT repeats (residues 200–522,
3MBT) were generated by Stratagene’s QuikChange method. The
mutant protein was expressed and purified as previously described
[20]. Fluorescence polarization assays were performed as de-
scribed in [24].
Protein crystallization and Structure determination
Crystals of MBTD1 were obtained by macroseeding at 18uC
by vapor diffusion of hanging drops of 5 mlo f1 0 m g m l
21
protein solution mixed with 5 ml of a reservoir solution. The
reservoir solution contained 20% PEG 3350, 0.2M CaOAc. For
cryoprotection, crystals were soaked for a few seconds in a
reservoir solution containing 20% (wt/vol) glycerol. The crystals
were mounted in a cryoloop and subsequently flash-frozen in
liquid nitrogen. X-ray data were collected at 100 K on beamline
23ID-B of Advance Photon Source (APS) at Argonne National
Laboratory. A native data set was collected to 2.5 A ˚ resolution.
The crystal belongs to space group P212121, with unit cell
parameters a=70.31 A ˚,b=1 0 0 . 9 0A ˚, and c=135.30 A ˚.T h e r e
are two molecules in the asymmetric unit that have a VM of 2.42
A ˚3D a 2 1 and a solvent content of 48.2%. The structure of
MBTD1 was determined by molecular replacement using
PHASER [25] using the crystal structure of L3MBTL2 (PDB
code 3f70) as a search model. Automated building was done with
ARP/wARP [26] and manual intervention for corrections.
Refinement was carried out using REFMAC [27] in CCP4.
The progress of refinement was monitored with Rfree and
inspection of 2|Fo|2|Fc| and |Fo|2|Fc| maps in COOT
[28]. When Rfree reached 29.8%, TLS refinement was applied
and the Rfree dropped to 27.4%. Stereochemical analysis was
done with Molprobity. The human L3MBTL1 R467C mutant
crystals were grown and its structure was solved using the same
methods as we previously reported for their wild-type counter-
part [20].
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